158 related articles for article (PubMed ID: 36362627)
1. Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer.
Zhao L; Li M; Zhang S; Liu Y
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362627
[TBL] [Abstract][Full Text] [Related]
2. Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer.
Zhao L; Liu Y; Zhang S; Li M
Biomed Res Int; 2022; 2022():6548945. PubMed ID: 36246966
[TBL] [Abstract][Full Text] [Related]
3. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37608077
[TBL] [Abstract][Full Text] [Related]
4. A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers.
Xu J; Song J; Wang T; Zhu W; Zuo L; Wu J; Guo J; Yang X
Epigenomics; 2021 Oct; 13(19):1557-1570. PubMed ID: 34632818
[TBL] [Abstract][Full Text] [Related]
5. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
6.
Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
[TBL] [Abstract][Full Text] [Related]
7. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
8. Opportunistic screening and survival prediction of digestive cancers by the combination of blood
Song L; Chen Y; Gong Y; Wan J; Guo S; Liu H; Li Y; Zeng Z; Lu Y
Ther Adv Med Oncol; 2020; 12():1758835920962966. PubMed ID: 33403008
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
[TBL] [Abstract][Full Text] [Related]
10. The stool
Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Methylated
Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
Front Oncol; 2018; 8():247. PubMed ID: 30013949
[TBL] [Abstract][Full Text] [Related]
12. Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma.
Huang F; Yang G; Jiang H; Chen X; Yang Y; Yu Q; Pan B; Wang B; Guo W; Yang W; Zhang C
Technol Cancer Res Treat; 2022; 21():15330338221144510. PubMed ID: 36573042
[No Abstract] [Full Text] [Related]
13. Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer.
Cao CQ; Chang L; Wu Q
Transl Cancer Res; 2020 Nov; 9(11):7012-7021. PubMed ID: 35117307
[TBL] [Abstract][Full Text] [Related]
14. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.
Lee HS; Hwang SM; Kim TS; Kim DW; Park DJ; Kang SB; Kim HH; Park KU
Transl Oncol; 2013 Jun; 6(3):290-6. PubMed ID: 23730408
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
Hu J; Hu B; Gui YC; Tan ZB; Xu JW
Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
[TBL] [Abstract][Full Text] [Related]
16. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract][Full Text] [Related]
17. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis.
Shen N; Wang T; Li D; Zhu Y; Xie H; Lu Y
Front Genet; 2019; 10():887. PubMed ID: 31608117
[No Abstract] [Full Text] [Related]
19. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].
He N; Feng G; Zhang FN; Hao S; Li R; Zhao ZQ; Tian YW; Yan HL
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):265-270. PubMed ID: 37137852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
